Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

AJ Gelderblom, Jaap Verweij, K (Kees) Nooter, A Sparreboom

Research output: Contribution to journal › Article › Academic › peer-review

1392 Citations (Scopus)

Access to Document

@article{b9f798528cd5431eb0b0a55b5fdd756e,

title = "Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.",

author = "AJ Gelderblom and Jaap Verweij and Nooter, {K (Kees)} and A Sparreboom",

year = "2001",

doi = "10.1016/S0959-8049(01)00171-X",

language = "Undefined/Unknown",

volume = "37",

pages = "1590--1598",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

AU - Gelderblom, AJ

AU - Verweij, Jaap

AU - Nooter, K (Kees)

AU - Sparreboom, A

PY - 2001

Y1 - 2001

U2 - 10.1016/S0959-8049(01)00171-X

DO - 10.1016/S0959-8049(01)00171-X

M3 - Article

VL - 37

SP - 1590

EP - 1598

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -